tiprankstipranks
Waters Corp. (WAT)
NYSE:WAT
US Market
Want to see WAT full AI Analyst Report?

Waters (WAT) Stock Forecast & Price Target

440 Followers
See the Price Targets and Ratings of:

WAT Analyst Ratings

Moderate Buy
16Ratings
Moderate Buy
8 Buy
8 Hold
0 Sell
Based on 16 analysts giving stock ratings to
Waters
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WAT Stock 12 Month Forecast

Average Price Target

$380.56
▲(16.10% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for Waters in the last 3 months. The average price target is $380.56 with a high forecast of $470.00 and a low forecast of $301.88. The average price target represents a 16.10% change from the last price of $327.77.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"289":"$289","380":"$380","471":"$471","334.5":"$334.5","425.5":"$425.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":470,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$470.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":380.555,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$380.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":301.88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$301.88</span>\n  </div></div>","useHTML":true}}],"tickPositions":[289,334.5,380,425.5,471],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,307.12,319.64923076923077,332.17846153846153,344.7076923076923,357.23692307692306,369.7661538461538,382.2953846153846,394.8246153846154,407.3538461538461,419.88307692307694,432.41230769230765,444.94153846153847,457.47076923076924,{"y":470,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,307.12,312.76884615384614,318.41769230769233,324.06653846153847,329.7153846153846,335.3642307692308,341.01307692307694,346.6619230769231,352.3107692307692,357.9596153846154,363.60846153846154,369.2573076923077,374.90615384615387,{"y":380.555,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,307.12,306.7169230769231,306.31384615384616,305.91076923076923,305.5076923076923,305.1046153846154,304.70153846153846,304.29846153846154,303.8953846153846,303.4923076923077,303.08923076923077,302.68615384615384,302.2830769230769,{"y":301.88,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":341.83,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":343.68,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":357.04,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.31,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":296.48,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":319.81,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":349.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":397.79,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":379.83,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":379.31,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":307.23,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":299.89,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":307.12,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$470.00Average Price Target$380.56Lowest Price Target$301.88
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank  Analyst forecast on WAT
Deutsche Bank
Deutsche Bank
$330$350
Hold
6.78%
Upside
Reiterated
05/07/26
Waters price target raised to $350 from $330 at Deutsche BankWaters price target raised to $350 from $330 at Deutsche Bank
Barclays Analyst forecast on WAT
Barclays
Barclays
$400$425
Buy
29.66%
Upside
Reiterated
05/07/26
Barclays Sticks to Their Buy Rating for Waters (WAT)
TD Cowen
$345$385
Hold
17.46%
Upside
Assigned
05/06/26
Daniel Brennan Lifts Waters Price Target to $385 but Maintains Hold on Balanced Risk‑Reward and BD Uncertainty
Guggenheim Analyst forecast on WAT
Guggenheim
Guggenheim
$440
Buy
34.24%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Waters (NYSE: WAT) and Context Therapeutics (NASDAQ: CNTX)
Robert W. Baird
$362$387
Buy
18.07%
Upside
Reiterated
05/06/26
Waters price target raised to $387 from $362 at BairdWaters price target raised to $387 from $362 at Baird
UBS
$330$375
Hold
14.41%
Upside
Reiterated
05/06/26
Waters price target raised to $375 from $330 at UBSWaters price target raised to $375 from $330 at UBS
Goldman Sachs Analyst forecast on WAT
Goldman Sachs
Goldman Sachs
$375$380
Buy
15.93%
Upside
Reiterated
05/06/26
Waters (WAT) Receives a Buy from Goldman Sachs
J.P. Morgan Analyst forecast on WAT
J.P. Morgan
J.P. Morgan
$330$345
Hold
5.26%
Upside
Assigned
05/06/26
Waters price target raised to $345 from $330 at JPMorganWaters price target raised to $345 from $330 at JPMorgan
Bank of America Securities Analyst forecast on WAT
Bank of America Securities
Bank of America Securities
$350$370
Hold
12.88%
Upside
Reiterated
05/05/26
Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (NASDAQ: JAZZ), Dianthus Therapeutics (NASDAQ: DNTH) and Waters (NYSE: WAT)
Evercore ISI Analyst forecast on WAT
Evercore ISI
Evercore ISI
$350
Buy
6.78%
Upside
Reiterated
05/05/26
Waters (WAT) Receives a Buy from Evercore ISI
Morgan Stanley Analyst forecast on WAT
Morgan Stanley
Morgan Stanley
$350
Hold
6.78%
Upside
Reiterated
05/05/26
Equal-Weight Maintained on Waters as Integration Progresses; Price Target Reaffirmed at $350
William Blair Analyst forecast on WAT
William Blair
William Blair
$301.88
Buy
-7.90%
Downside
Reiterated
05/05/26
Analyst Reiterates Buy on Waters as Pharma Demand, BD Synergies and Earnings Outlook Drive Positive Risk-Reward
Stifel Nicolaus Analyst forecast on WAT
Stifel Nicolaus
Stifel Nicolaus
$380
Hold
15.93%
Upside
Reiterated
05/04/26
Analysts Offer Insights on Healthcare Companies: Waters (NYSE: WAT) and Assertio Therapeutics (NASDAQ: ASRT)
Citi
$425
Buy
29.66%
Upside
Assigned
04/07/26
Citi Sticks to Its Buy Rating for Waters (WAT)
Wells Fargo
$415$355
Hold
8.31%
Upside
Reiterated
02/11/26
Waters (WAT) Receives a Hold from Wells Fargo
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank  Analyst forecast on WAT
Deutsche Bank
Deutsche Bank
$330$350
Hold
6.78%
Upside
Reiterated
05/07/26
Waters price target raised to $350 from $330 at Deutsche BankWaters price target raised to $350 from $330 at Deutsche Bank
Barclays Analyst forecast on WAT
Barclays
Barclays
$400$425
Buy
29.66%
Upside
Reiterated
05/07/26
Barclays Sticks to Their Buy Rating for Waters (WAT)
TD Cowen
$345$385
Hold
17.46%
Upside
Assigned
05/06/26
Daniel Brennan Lifts Waters Price Target to $385 but Maintains Hold on Balanced Risk‑Reward and BD Uncertainty
Guggenheim Analyst forecast on WAT
Guggenheim
Guggenheim
$440
Buy
34.24%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Waters (NYSE: WAT) and Context Therapeutics (NASDAQ: CNTX)
Robert W. Baird
$362$387
Buy
18.07%
Upside
Reiterated
05/06/26
Waters price target raised to $387 from $362 at BairdWaters price target raised to $387 from $362 at Baird
UBS
$330$375
Hold
14.41%
Upside
Reiterated
05/06/26
Waters price target raised to $375 from $330 at UBSWaters price target raised to $375 from $330 at UBS
Goldman Sachs Analyst forecast on WAT
Goldman Sachs
Goldman Sachs
$375$380
Buy
15.93%
Upside
Reiterated
05/06/26
Waters (WAT) Receives a Buy from Goldman Sachs
J.P. Morgan Analyst forecast on WAT
J.P. Morgan
J.P. Morgan
$330$345
Hold
5.26%
Upside
Assigned
05/06/26
Waters price target raised to $345 from $330 at JPMorganWaters price target raised to $345 from $330 at JPMorgan
Bank of America Securities Analyst forecast on WAT
Bank of America Securities
Bank of America Securities
$350$370
Hold
12.88%
Upside
Reiterated
05/05/26
Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (NASDAQ: JAZZ), Dianthus Therapeutics (NASDAQ: DNTH) and Waters (NYSE: WAT)
Evercore ISI Analyst forecast on WAT
Evercore ISI
Evercore ISI
$350
Buy
6.78%
Upside
Reiterated
05/05/26
Waters (WAT) Receives a Buy from Evercore ISI
Morgan Stanley Analyst forecast on WAT
Morgan Stanley
Morgan Stanley
$350
Hold
6.78%
Upside
Reiterated
05/05/26
Equal-Weight Maintained on Waters as Integration Progresses; Price Target Reaffirmed at $350
William Blair Analyst forecast on WAT
William Blair
William Blair
$301.88
Buy
-7.90%
Downside
Reiterated
05/05/26
Analyst Reiterates Buy on Waters as Pharma Demand, BD Synergies and Earnings Outlook Drive Positive Risk-Reward
Stifel Nicolaus Analyst forecast on WAT
Stifel Nicolaus
Stifel Nicolaus
$380
Hold
15.93%
Upside
Reiterated
05/04/26
Analysts Offer Insights on Healthcare Companies: Waters (NYSE: WAT) and Assertio Therapeutics (NASDAQ: ASRT)
Citi
$425
Buy
29.66%
Upside
Assigned
04/07/26
Citi Sticks to Its Buy Rating for Waters (WAT)
Wells Fargo
$415$355
Hold
8.31%
Upside
Reiterated
02/11/26
Waters (WAT) Receives a Hold from Wells Fargo
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Waters

3 Months
xxx
Success Rate
11/15 ratings generated profit
73%
Average Return
+4.82%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +4.82% per trade.
1 Year
Success Rate
12/15 ratings generated profit
80%
Average Return
+10.25%
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +10.25% per trade.
2 Years
xxx
Success Rate
14/15 ratings generated profit
93%
Average Return
+15.71%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 93.33% of your transactions generating a profit, with an average return of +15.71% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WAT Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
7
14
12
11
10
Hold
10
10
8
8
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
24
20
19
21
In the current month, WAT has received 10 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. WAT average Analyst price target in the past 3 months is 380.56.
Each month's total comprises the sum of three months' worth of ratings.

WAT Financial Forecast

WAT Earnings Forecast

Next quarter’s earnings estimate for WAT is $2.99 with a range of $2.95 to $3.03. The previous quarter’s EPS was $2.70. WAT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year WAT has Performed in-line its overall industry.
Next quarter’s earnings estimate for WAT is $2.99 with a range of $2.95 to $3.03. The previous quarter’s EPS was $2.70. WAT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year WAT has Performed in-line its overall industry.

WAT Sales Forecast

Next quarter’s sales forecast for WAT is $1.62B with a range of $1.60B to $1.64B. The previous quarter’s sales results were $1.27B. WAT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year WAT has Performed in-line its overall industry.
Next quarter’s sales forecast for WAT is $1.62B with a range of $1.60B to $1.64B. The previous quarter’s sales results were $1.27B. WAT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year WAT has Performed in-line its overall industry.

WAT Stock Forecast FAQ

What is WAT’s average 12-month price target, according to analysts?
Based on analyst ratings, Waters Corp.’s 12-month average price target is 380.56.
    What is WAT’s upside potential, based on the analysts’ average price target?
    Waters Corp. has 16.10% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is WAT a Buy, Sell or Hold?
          Waters Corp. has a consensus rating of Moderate Buy which is based on 8 buy ratings, 8 hold ratings and 0 sell ratings.
            What is Waters Corp.’s price target?
            The average price target for Waters Corp. is 380.56. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $470.00 ,the lowest forecast is $301.88. The average price target represents 16.10% Increase from the current price of $327.77.
              What do analysts say about Waters Corp.?
              Waters Corp.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.
                How can I buy shares of WAT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.